総説・原著論文等
１）国際誌
Akatani N, Wakabayashi H, Kayano D, Inaki A, Takata A, Hiromasa T, Yamase T,Kunita Y, Watanabe S, Mori H, Saito S, Nakajima K, Kinuya S.
Long-term outcomes and prognostic factors of patients with lung metastases fromdifferentiated thyroid cancer after radioiodine therapy in Japan Endocr J.
2023;70(3):315-322
Nakajima K, Miyauchi H, Hirano K, Fujimoto S, Kawahito M, Iimori T, Kudo T.
Practice recommendation for measuring washout rates in 123I-BMIPP fatty acidimages Ann Nucl Cardiol. 2023;9(1):3-10
Nakajima K, Miyauchi H, Hirano K, Fujimoto S, Kawahito M, Iimori T, Kudo T.
Practice recommendation for measuring washout rates in 123I-BMIPP fatty acidimages Ann Nucl Med. 2024;38(1):1-8.
Nakajima K, Nishimura T.
J-ACCESS investigation and nuclear cardiology in Japan: implications for heart
failure Ann Nucl Med. 2023;37(6):317-327.
Nakajima K, Shibutani T.
Are nuclear medicine images quantified in 2D and 3D equally functional?
J Nucl Cardiol. 2023;30(5):1968-1972.
Nakajima K, Shibutani T, Massanes F, Shimizu T, Yoshida S, Onoguchi M, Kinuya
S, Vija AH Myocardial perfusion imaging with retrospective gating andintegrated correction of attenuation, scatter, respiration, motion, andarrhythmia J Nucl Cardiol. 2023;30(6):2773-2789.
Nakajima K, Tada H Seeing is believing: Visualization of multivariable riskmodels J Nucl Cardiol. 2023;30(2):764-768.
Saito S, Nakajima K, Shibutani T, Wakabayashi H, Yoneyama H, Konishi T, Mori
H, Takata A, Kinuya S.

Three-Dimensional Heart Segmentation and Absolute Quantitation of Cardiac 123Imetaiodobenzylguanidine Sympathetic Imaging Using SPECT/CT Ann Nucl Cardiol.
2023;9(1):61-67.
Wakabayashi H, Mori H, Hiromasa T, Akatani N, Inaki A, Kozaka T, Kitamura Y,Ogawa K, Kinuya S, Taki J.
125

I-labeled2-[4-(2-iodophenyl)piperidino]cyclopentanol(125I-OI5V)

imagingvisualized augmented sigma-1 receptor expression according to the severity of
myocardial ischemia J Nucl Cardiol. 2023;30(2):653-661.
Watanabe S, Nakajima K, Toshima F, Wakabayashi H, Yoshida S, Yoneyama H, Komatsu
J, Konishi T, Kinuya S.
Transthyretin amyloid cardiomyopathy disease burden quantified using99m

Tc-pyrophosphate SPECT/CT: volumetric parameters versus SUVmax ratio at 1 and 3
hours J Nucl Cardiol. 2023;30(6):2721-2735.
Zhang X, Wakabayashi H, Hiromasa T, Kayano D, Kinuya S.
Recent Advances in Radiopharmaceutical Theranostics of Pheochromocytoma andParaganglioma Semin Nucl Med. 2023;53(4):503-516.
Araki Y, Yamamoto N, Hayashi K, Takeuchi A, Miwa S, Igarashi K, Higuchi T, AbeK, Taniguchi Y, Yonezawa H, Morinaga S, Asano Y, Nojima T, Taki J, Tsuchiya H
A Viability Analysis of Tumor-Bearing Frozen Autograft for the Reconstruction
After Resection of Malignant Bone Tumors Using 99mTc-MDP Scintigraphy Clin Nucl
Med. 2023;48(1):25-34.
Echigo H, Mishiro K, Munekane M, Fuchigami T, Washiyama K, Takahashi K, Kitamura
Y, Wakabayashi H, Kinuya S, Ogawa K.
Development of probes for radiotheranostics with albumin binding moiety toincrease the therapeutic effects of astatine-211 (211At) Eur J Nucl Med Mol
Imaging. 2024;51(2):412-421.
Hirano K, Higashi M, Nakajima K.
Remarkable regression of diffuse coronary atherosclerosis in patients withtriglyceride deposit cardiomyovasculopathy Eur Heart J. 2023;44(13):1191.

Hirano K, Kodama K, Miyauchi H, Nagasawa Y, Nakano Y, Matsunaga M, Amano T,Nakajima K.
Carnitine Administration and 123I-BMIPP Washout Rate in Hemodialysis Patientswith Triglyceride Deposit Cardiomyovasculopathy Ann Nucl Cardiol. 2023 Dec 22.
doi:10.17996/anc.23-00014
Liao J, Misaki K, Uno T, Nambu I, Kamide T, Chen Z, Nakada M, Sakamoto J
Fluid dynamic analysis in predicting the recanalization of intracranial
aneurysms after coil embolization – A study of spatiotemporal characteristics
Heliyon. 2023;10(1):e22801
Mishiro K, Ueno T, Wakabayashi H, Fukui M, Kinuya S, Ogawa K
Synthesis and evaluation of a deltic guanidinium analogue of a cyclic RGD
peptide Org Biomol Chem. 2023;21(9):1937-1941.
Mishiro K, Imai S, Ematsu Y, Hirose K, Fuchigami T, Munekane M, Kinuya S, Ogawa
K.
RGD Peptide-Conjugated Dodecaborate with the Ga-DOTA Complex: A Preliminary
Study for the Development of Theranostic Agents for Boron Neutron Capture
Therapy and Its Companion Diagnostics J Med Chem. 2023:65(24):16741-16753.
Ogawa K, Nishizawa K, Washiyama K, Munekane M, Fuchigami T, Echigo H, MishiroK, Hirata S, Wakabayashi H, Takahashi K, Kinuya S.
Astatine-211-labeled aza-vesamicol derivatives as sigma receptor ligands fortargeted alpha therapy Nucl Med Biol. 2023;122-123:108369
Okuda K, Nakajima K, Hung G, Wu H, Verschure DO, Verberne HJ, Kitamura C.
Comparison of Taiwanese and European Calibration Factors for Heart-toMediastinum Ratio in Multicenter 123I-mIBG Phantom Studies Ann Nucl Cardiol.
2023;9(1):54-60.
Okuda K, Nakajima K, Kitamura C, Ljungberg M, Hosoya T, Kirihara Y, Hashimoto
M.
Machinelearning-based

prediction

ofconversion

metaiodobenzylguanidine heart-to-mediastinum ratio
J Nucl Cardiol. 2023;30(4):1630-1641.

coefficientsforI-123

Shibutani T, Konishi T, Ichikawa H, Onoguchi M, Yoneyama H, Ito T, Okuda K,Nakajima K.
Detectability of cold tumors by xSPECT bone technology compared with hot tumors:a supine phantom study.Phys Eng Sci Med. 2023 Dec 20. doi:10.1007/s13246-02301364-y
Shibutani T, Onoguchi M, Kanno T, Kinuya S.
Influence of spill-over for 99mTc images and the effect of scatter correction
for dual-isotope simultaneous acquisition with 99mTc and 18F using small-animal
SPECT-PET/CT system. Phys Eng Sci Med. 2023 Oct 30. doi: 10.1007/s13246-02301348-y
Shibutani T, Onoguchi M, Kanno T, Wakabayashi H, Hiromasa T, Kinuya S
Development of a novel small-animal myocardial phantom can evaluate the image
qualityofdual-isotope

simultaneousacquisition(DISA)

AnnNuclMed

2023:36(12):1031-1038.
Takamatsu A, Yoshida K, Watanabe S, Komori T, Inoue D, Taki J, Gabata T
Comparison of 18F-FDG PET Findings of Pegfilgrastim-Induced Aortitis With Other
Types of Large-Vessel Vasculitis: A Retrospective Observational Study
Clin Nucl Med. 2023;48(12):1028-1034.
Takeshita Y, Nomura C, Murai H, Mukai Y, Hirai T, Hamaoka T, Tokuno S, TanakaT, Goto H, Nakano Y, Usui S, Nakajima K, Takamura M, Takamura TStudy Protocol for the Pleiotropic Effects of Sodium-Glucose Cotransporter 2Inhibitor on Organ-Specific Sympathetic Nerve Activity and Insulin Sensitivity
in Participants with Type 2 Diabetes. Diabetes Ther. 2024;15(1):269-280.
Terashima T, Yamashita T, Takemura N, Inaki A, Shimizu A, Harada K, YamashitaT, Kinuya S, Hanada K.
Acaseoffrequent

hypoglycemic

capecitabine plus temozolomide andattacks

successfully

controlledwith177

Lu-DOTATATE peptide receptor radionuclide

therapy in a patient with recurrent pancreatic insulinoma Clin J Gastroenterol.
2023;16(5):767-771.

Urbain JL, Scott AM, Lee ST, Buscombe J, Weston C, Hatazawa J, Kinuya S, SinghB, Haidar M, Ross A, Lamoureux F, Kunikowska J, Wadsak W, Dierckx R, Paez D,Giammarile F, Lee KH, O JH, Moshe M, Louw L, More S, Nadel H, Lee D, Wahl R.
Theranostic Radiopharmaceuticals: A Universal Challenging Educational Paradigm
in Nuclear Medicine J Nucl Med. 2023;64(6):986-991.
Yamashita S, Nakajima K, Okuda K, Yamamoto H, Shibutani T, Yoneyama Tm Tsuji
S, Yokoyama K.
Phantom-Based Standardization Method for 123I-meta- iodobenzylguanidine Heartto-Mediastinum Ratio Validated by D-SPECT Versus Anger Camera
Ann Nucl Cardiol. 2023;9(1):85-90.
Yoshida S, Nakata T, Naya M, Momose M, Taniguchi Y, Fukushima Y, Moroi M,
Okizaki A, Hashimoto A, Kiko T, Hida S, Takehana K, Nakajima K.
Prognostic Implications of Sarcoidosis Granulomas- Insights From theMulticenter Registry, the Japanese Cardiac Sarcoidosis Prognostic Study
Circ Rep. 2023;5(6):252-259.
２）和文誌
赤谷憲一、若林大志、絹谷清剛
ペプチド受容体放射性核種療法の原理と基礎
胆と膵 2023;44(1):61-67
絹谷清剛「特集１．内分泌腫瘍における核医学治療―現状と将来」によせて
日本内分泌外科学会雑誌 2023;40(1):1
國田優志、森博史、絹谷清剛
褐色細胞腫・パラガングリオーマに対する核医学治療
臨床泌尿器科 2023;77(10):806-812
廣正智、張雪、森博史、若林大志、萱野大樹、絹谷清剛【内分泌腫瘍における核医学治療―現状と将来】褐色細胞腫バラガングリオーマ
日本内分泌外科学会雑誌 2023;40(1):7-11

森 博史、廣正 智、若林 大志、萱野 大樹、絹谷 清剛【内分泌腫瘍における核医学治療―現状と将来】ペプチド受容体放射性核種療法
日本内分泌外科学会雑誌 2023;40(1):2-6
森 博史、若林 大志、廣正 智、稲木 杏吏、萱野 大樹、絹谷 清剛
Refresher Course 核医学クイックレビュー 第 3 回 最近話題の核医学治療
画像診断 2023;43(5):469-476
若林大志、張 雪、萱野大樹、絹谷清剛難治性褐色細胞腫、傍神経節腫に対する 131I-metaiodobenzyl-guanidine
糖尿病、内分泌代謝科 2023;58(5):1-8
若林大志、張 雪、萱野大樹、絹谷清剛
難治性褐色細胞腫、傍神経節腫に対する 131I-metaiodobenzylguanidine 治療
糖尿病・内分泌代謝科 2023;56(5):669-676
渡辺 悟、廣正 智、萱野 大樹、中嶋 憲一
2023 年における核医学の最新動向と予想
Rad Fan 2023;21(4):72-77
３）和書籍
絹谷清剛、若林大志、米山寛人、小西貴広、小川数馬、小野口昌久、澁谷孝行、松田博史、久慈一英、瀬戸 陽、今林悦子、中嶋憲一、瀧 淳一、松成一朗、渡辺悟、福岡誠、稲木杏吏、赤谷憲一、國田優志、横山邦彦、山瀬喬史、廣正 智、森 博史、高田亜希、萱野大樹
新 核医学テキスト 2023;420 頁:中外医学社